Nineteen patients with LHON were included in this study.
Mitochondrial DNA analysis confirmed point mutations at positions
11,778 (12 cases), 3460 (2 cases), and 14,484(5 cases). All patients
were men, with a median age of 37 years (range, 21–71 years). In all
cases the visual loss was chronic, with on average 12.4 years (range,
2–32 years) between visual loss and evaluation in this study. For
comparison, we examined 24 control subjects with healthy eyes (M:F
ratio, 12:11; median age, 28 years [32 years in the male subjects]),
range, 21–51 years); all control subjects had normal visual function
with corrected Snellen acuities of 6/6 or better. Pupil and visual
function were assessed after a minimum of 10 minutes preadaptation to
mesopic conditions, and only the preferred eye was tested in each case.
All patient and control subjects gave their informed consent before
participating in this study, and the research followed the tenets of
the Declaration of Helsinki.